Reddit Inc vs TG Therapeutics Inc — how do they compare? Reddit Inc trades at $170.15 (market cap $35.78B), while TG Therapeutics Inc trades at $52.7 (market cap $8.26B). The key difference: Reddit Inc is far larger — about 4.3× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.
| RDDT | TGTX | |
|---|---|---|
Market Cap | $35.78B | $8.26B |
Sector | Media | Health |
52-Week High | $270.71 | $59.06 |
52-Week Low | $121.84 | $26.39 |
Enterprise Value | $33.03B | $8.50B |
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $181.67, up 0.21% today, with a bearish technical signal but strong fundamentals including 91.37% gross margins and recent earnings beats. Analyst consensus is bullish with a $236.89 price target, and institutional interest is rising, as seen with Andra AP fonden's 152.6% stake increase in Q1 2026 (SEC filing, July 21, 2026).
The outlook is positive due to robust revenue growth and AI initiatives, but risks include high valuation multiples and competitive pressures. Near-term focus is on Q2 2026 earnings due July 30, 2026, which could drive volatility.
TG Therapeutics (TGTX) trades at $53.96, down 1.6% today, with a bullish technical signal and strong profitability metrics including a 65.95% net income margin. Recent news highlights clinical progress, including a Phase 2 trial for Briumvi in schizophrenia (Zacks Investment Research, 2026-07-07) and positive Phase 1 data for subcutaneous Briumvi (GlobeNewsWire, 2026-06-03). However, earnings misses in Q4 2025 and Q1 2026 and a shareholder investigation (PRNewsWire, 2026-07-21) introduce volatility.
The outlook is mixed: analyst consensus is strongly bullish (84.6% buy ratings) with a $48.50 price target, but near-term risks from legal scrutiny and earnings inconsistency warrant caution. Upside hinges on successful drug trials and sales growth, while downside risks include legal outcomes and competitive pressures in the biotech sector.
Trailing returns across standard periods
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →